World's Best Scientists 2026 revealed!
Bruno Ledergerber

Bruno Ledergerber

Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
98
Citations
42390
World Ranking
8827
National Ranking
121

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Bruno Ledergerber is affiliated with the University of Zurich in Switzerland. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on subfields such as Infectious Diseases, Virology, Emergency Medicine, Epidemiology, and Surgery.

The main topics covered in their work include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • HIV, Drug Use, Sexual Risk
  • Telomeres, Telomerase, and Senescence
  • Infective Endocarditis Diagnosis and Management

Ledergerber has contributed extensively to the academic literature, with frequent publications in several medical journals. Key venues for their work include:

  • The Journal of Infectious Diseases
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • International Journal of Epidemiology

Their recent papers demonstrate an active engagement with various aspects of infectious disease research and treatment. Notable recent publications include:

  • "Cohort Profile Update: The Swiss HIV Cohort Study (SHCS)" (2021), published in the International Journal of Epidemiology
  • "A highly virulent variant of HIV-1 circulating in the Netherlands" (2022), published in Science
  • "A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study" (2020), published in Clinical Infectious Diseases
  • "Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years" (2023), published in The Lancet Healthy Longevity
  • "Changes in Renal Function After Switching From TDF to TAF in HIV-Infected Individuals: A Prospective Cohort Study" (2020), published in The Journal of Infectious Diseases

Ledergerber often collaborates with other researchers, with frequent co-authors including:

  • Huldrych F. Günthard
  • Matthias Cavassini
  • Enos Bernasconi
  • Roger D. Kouyos
  • Philip Tarr

Best Publications

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

    Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips

  • Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

    Lewis H Kuller;Russell Tracy;Waldo Belloso;Stephane De Wit

  • Decline in the AIDS and death rates in the EuroSIDA study: an observational study

    A Mocroft;B Ledergerber;C Katlama;O Kirk

  • A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1

    Jacques Fellay;Kevin V. Shianna;Dongliang Ge;Sara Colombo

  • Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

    Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss

  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

    Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob

  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

    Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti

  • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

    Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf

  • Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies

    J Gill;Margaret T May;C Lewden;M Saag

  • Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.

    Jonathan A C Sterne;Miguel A Hernán;Bruno Ledergerber;Kate Tilling

  • Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

    Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay

  • Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort

    Deborah Konopnicki;Amanda Mocroft;S. De Wit;Francisco Antunes

  • Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

    Daniel A. Duprez;Jacqueline Neuhaus;Lewis H. Kuller;Russell Tracy

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy

    Jiirgen K. Rockstroh;Amanda Mocroft;Vincent Soriano;Cristina Tural

  • Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe

    Mocroft A;Kirk O;Barton Se;Dietrich M

  • Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

    Amanda Mocroft;Ole Kirk;Peter Reiss;Stephane De Wit

  • Cohort profile: the Swiss HIV Cohort study

    Franziska Schoeni-Affolter;Bruno Ledergerber;Martin Rickenbach;Christoph Rudin

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

Frequent Co-Authors

Rainer Weber
Rainer Weber University of Zurich
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Hansjakob Furrer
Hansjakob Furrer University of Bern
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Manuel Battegay
Manuel Battegay University Hospital of Basel
Matthias Cavassini
Matthias Cavassini University of Lausanne
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Andrew N. Phillips
Andrew N. Phillips University College London
Amanda Mocroft
Amanda Mocroft University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering medical studies in the USA, online degrees offer flexible options that support both clinical and academic growth. Many aspiring healthcare professionals start with online nursing programs, which combine convenient study schedules with accredited coursework, making it easier to balance work, life, and education.

Those aiming to advance their roles can explore the cheapest np school online, providing a pathway for registered nurses to become nurse practitioners without hefty student debt. Similarly, the most affordable accredited online rn to bsn programs enable current RNs to earn a bachelor’s degree, unlocking more career opportunities.

Ambitious nurses interested in teaching or research can pursue online phd programs nursing. This online path helps students reach advanced roles such as nursing faculty or healthcare policy experts, all from the comfort of their homes. These related degrees and pathways highlight the growing accessibility of healthcare education online, catering to varied interests and budgets.

Best Scientists Citing Bruno Ledergerber

Trending Scientists